Literature DB >> 26631955

CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells.

Xi Zhou1, Yu-Xiong Su2, Xiao-Mei Lao1, Yu-Jie Liang3, Gui-Qing Liao4.   

Abstract

OBJECTIVES: Increase of regulatory T cells (Tregs) in the tumor microenvironment predicts worse survival of patients with various types of cancer including tongue squamous cell carcinoma (TSCC). Recently, the cross-talk between Tregs and regulatory B cells (Bregs) has been shown in several tumor models. However the relevance of Bregs to tumor immunity in humans remains elusive. Our objective was to investigate the distribution and function of Bregs in TSCC microenvironment.
MATERIALS AND METHODS: Double staining (Bregs: IL10/CD19 and Tregs: Foxp3/CD4) was performed on tissue sections of 46 TSCC, 20 metastasis lymph nodes, and tumor adjacent normal tissue. Flow cytometry analysis was used to detect the Bregs from magnetic bead-sorted B cells after co-culture with TSCC cell lines, and Tregs from sorted CD4(+)CD25(-) T cells after co-culture with stimulated B cells.
RESULTS: The immunohistochemical (IHC) results showed that the frequency of Bregs/CD19(+) B in TSCC (0.80±0.08%) was significantly higher than adjacent normal tissue (0.52±0.04% p<0.01). And the increase of Bregs in TSCC microenvironment was related to Tregs and predicts worse survival in patients. Cytological experiments indicated that frequency of Bregs increased after co-culture with TSCC cell line and that the induced B cells converted CD4(+)CD25(-) T cells into Tregs.
CONCLUSION: The increased expression of Bregs in the TSCC microenvironment plays a significant role in the differentiation of resting CD4(+) T cells and influenced the prognosis of TSCC patients.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bregs; CD40L; Double staining; IL-10; Immunosuppression; Oral oncology; Tongue squamous cell carcinoma; Tregs; Tumor immunity; Tumor microenvironment

Mesh:

Substances:

Year:  2015        PMID: 26631955     DOI: 10.1016/j.oraloncology.2015.11.003

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  51 in total

Review 1.  B cells, plasma cells and antibody repertoires in the tumour microenvironment.

Authors:  George V Sharonov; Ekaterina O Serebrovskaya; Diana V Yuzhakova; Olga V Britanova; Dmitriy M Chudakov
Journal:  Nat Rev Immunol       Date:  2020-01-27       Impact factor: 53.106

2.  TGF-βR inhibitor SB431542 restores immune suppression induced by regulatory B-T cell axis and decreases tumour burden in murine fibrosarcoma.

Authors:  Kavitha Premkumar; Bhavani S Shankar
Journal:  Cancer Immunol Immunother       Date:  2020-07-13       Impact factor: 6.968

3.  Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non-Small Cell Lung Cancer Patients.

Authors:  Tullia C Bruno; Peggy J Ebner; Brandon L Moore; Olivia G Squalls; Katherine A Waugh; Evgeniy B Eruslanov; Sunil Singhal; John D Mitchell; Wilbur A Franklin; Daniel T Merrick; Martin D McCarter; Brent E Palmer; Jeffrey A Kern; Jill E Slansky
Journal:  Cancer Immunol Res       Date:  2017-08-28       Impact factor: 11.151

4.  Runx2 Suppression by miR-342 and miR-363 Inhibits Multiple Myeloma Progression.

Authors:  Pramod S Gowda; Benjamin J Wildman; Timothy N Trotter; Xiaoxuan Xu; Xiaoxiao Hao; Mohammad Q Hassan; Yang Yang
Journal:  Mol Cancer Res       Date:  2018-03-28       Impact factor: 5.852

Review 5.  [B cells in head and neck oncology].

Authors:  P J Schuler; C Brunner; T K Hoffmann
Journal:  HNO       Date:  2018-04       Impact factor: 1.284

6.  Use of Toll-Like Receptor (TLR) Ligation to Characterize Human Regulatory B-Cells Subsets.

Authors:  Mathilde A M Chayé; Chiara Tontini; Arifa Ozir-Fazalalikhan; Astrid L Voskamp; Hermelijn H Smits
Journal:  Methods Mol Biol       Date:  2021

Review 7.  The Microenvironment of Tongue Cancer.

Authors:  Want Tao; Zeng Li-Juan; Li Kan; Li Jing-Yuan; Liu Xiang-Qi; Liang Yu-Jie
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 8.  Tumor-infiltrating lymphocytes in the immunotherapy era.

Authors:  Sterre T Paijens; Annegé Vledder; Marco de Bruyn; Hans W Nijman
Journal:  Cell Mol Immunol       Date:  2020-11-02       Impact factor: 11.530

Review 9.  Immunosuppressive Mechanisms of Regulatory B Cells.

Authors:  Diego Catalán; Miguel Andrés Mansilla; Ashley Ferrier; Lilian Soto; Kristine Oleinika; Juan Carlos Aguillón; Octavio Aravena
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

Review 10.  Regulatory B cells in cancer.

Authors:  Daniel Michaud; Colleen R Steward; Bhalchandra Mirlekar; Yuliya Pylayeva-Gupta
Journal:  Immunol Rev       Date:  2020-12-23       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.